Fiona McLaughlin

816 total citations
19 papers, 653 citations indexed

About

Fiona McLaughlin is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Fiona McLaughlin has authored 19 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Hematology and 5 papers in Immunology. Recurrent topics in Fiona McLaughlin's work include Epigenetics and DNA Methylation (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Fiona McLaughlin is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Fiona McLaughlin collaborates with scholars based in United Kingdom, Australia and United States. Fiona McLaughlin's co-authors include Nicholas B. La Thangue, Anna M. Randi, Ernesto Bockamp, Berthold Göttgens, Adele Murrell, Valerie J. Ludbrook, Anthony R. Green, Callum J. Campbell, Paul W. Finn and Andrew G. Elefanty and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Fiona McLaughlin

18 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona McLaughlin United Kingdom 12 440 122 96 94 90 19 653
Nasim Yousaf United Kingdom 13 390 0.9× 184 1.5× 71 0.7× 98 1.0× 64 0.7× 29 655
Colin Crean United States 13 377 0.9× 105 0.9× 89 0.9× 151 1.6× 77 0.9× 21 647
Desi Pan China 14 614 1.4× 82 0.7× 73 0.8× 248 2.6× 63 0.7× 23 882
Rashid Gabbasov United States 10 286 0.7× 91 0.7× 56 0.6× 158 1.7× 66 0.7× 21 525
Natasa Zamurovic Switzerland 9 365 0.8× 74 0.6× 28 0.3× 90 1.0× 29 0.3× 16 546
Hiroshi Shin Japan 8 197 0.4× 107 0.9× 160 1.7× 54 0.6× 125 1.4× 9 516
Matthew Adlam United States 10 509 1.2× 218 1.8× 65 0.7× 129 1.4× 26 0.3× 11 738
Esben Pedersen Denmark 12 528 1.2× 145 1.2× 245 2.6× 177 1.9× 38 0.4× 15 838
Mio Nakanishi Japan 14 606 1.4× 122 1.0× 34 0.4× 67 0.7× 113 1.3× 18 889
N. Vandeghinste Belgium 9 182 0.4× 154 1.3× 30 0.3× 170 1.8× 69 0.8× 15 586

Countries citing papers authored by Fiona McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Fiona McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona McLaughlin more than expected).

Fields of papers citing papers by Fiona McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona McLaughlin. The network helps show where Fiona McLaughlin may publish in the future.

Co-authorship network of co-authors of Fiona McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona McLaughlin. A scholar is included among the top collaborators of Fiona McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona McLaughlin. Fiona McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
McLaughlin, Fiona, et al.. (2021). A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression. Drugs in R&D. 21(3). 331–339. 1 indexed citations
3.
McAneney, Helen, et al.. (2020). Perspectives on a NI Rare Disease Registry. Research Portal (Queen's University Belfast). 1 indexed citations
4.
McLaughlin, Fiona, Frank Giles, Francis Sullivan, et al.. (2013). The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance. British Journal of Cancer. 109(8). 2131–2141. 10 indexed citations
6.
Doran, Benjamin A., et al.. (2008). 272 POSTER Activity of the anti-cancer aptamer AS1411 includes regulation of Bcl-2 family members. European Journal of Cancer Supplements. 6(12). 88–88. 1 indexed citations
7.
McLaughlin, Fiona & Nicholas B. La Thangue. (2004). Histone deacetylase inhibitors open new doors in cancer therapy. Biochemical Pharmacology. 68(6). 1139–1144. 120 indexed citations
8.
McLaughlin, Fiona & Nicholas B. La Thangue. (2004). Histone Deacetylase Inhibitors in Psoriasis Therapy. Current Drug Targets - Inflammation & Allergy. 3(2). 213–219. 23 indexed citations
9.
McLaughlin, Fiona, Paul W. Finn, & Nicholas B. La Thangue. (2003). The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age. Drug Discovery Today. 8(17). 793–802. 44 indexed citations
10.
McLaughlin, Fiona, J. Mackintosh, Iain Uings, et al.. (2002). Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone. 30(6). 924–930. 92 indexed citations
11.
12.
Göttgens, Berthold, et al.. (1999). Chromatin structure and transcriptional regulation of the stem cell leukaemia (SCL) gene in mast cells. Leukemia. 13(5). 750–759. 11 indexed citations
13.
McLaughlin, Fiona, et al.. (1999). True. Leukemia. 13(5). 750–759. 3 indexed citations
14.
McLaughlin, Fiona, Valerie J. Ludbrook, Ismail Kola, Callum J. Campbell, & Anna M. Randi. (1999). Characterisation of the tumour necrosis factor (TNF)-α response elements in the human ICAM-2 promoter. Journal of Cell Science. 112(24). 4695–4703. 40 indexed citations
15.
McLaughlin, Fiona, B. P. Hayes, Carmel M.T. Horgan, et al.. (1998). Tumor Necrosis Factor (TNF)-α and Interleukin (IL)-1β Down-regulate Intercellular Adhesion Molecule (ICAM)-2 Expression on the Endothelium. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 6(5). 381–400. 44 indexed citations
17.
Bockamp, Ernesto, Fiona McLaughlin, Berthold Göttgens, et al.. (1997). Distinct Mechanisms Direct SCL/tal-1 Expression in Erythroid Cells and CD34 Positive Primitive Myeloid Cells. Journal of Biological Chemistry. 272(13). 8781–8790. 41 indexed citations
18.
Bockamp, Ernesto, Fiona McLaughlin, Adele Murrell, et al.. (1995). Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood. 86(4). 1502–1514. 66 indexed citations
19.
Bockamp, Ernesto, Fiona McLaughlin, Adele Murrell, & Anthony R. Green. (1994). Transcription factors and the regulation of haemopoiesis: Lessons from GATA and SCL proteins. BioEssays. 16(7). 481–488. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026